Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral
- PMID: 23371291
- PMCID: PMC4759639
- DOI: 10.1158/1055-9965.EPI-12-1280
Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral
Abstract
Background: In 2005, the United States Preventive Services Task Force (USPSTF) released guidelines which outlined specific family history patterns associated with an increased risk for BRCA1/2 mutations, and recommended at-risk individuals be referred for genetic counseling and evaluation for BRCA testing. The purpose of this study was to assess the prevalence of individuals with a USPSTF increased-risk family history pattern, the frequency with which specific patterns were met, and resulting healthcare actions among women from the Henry Ford Health System.
Methods: As part of a study evaluating ovarian cancer risk perception and screening, 2,524 randomly selected participants completed a detailed interview (response rate 76%) from an initial eligible cohort of 16,720 women.
Results: Approximately 6% of participants had a family history fulfilling one or more of the USPSTF patterns. Although 90% of these women had shared their family history with their provider, less than 20% had been referred for genetic counseling and only 8% had undergone genetic testing. Caucasian women with higher income and education levels were more likely to receive referrals. Among the 95 participants in the total study cohort who reported BRCA testing, 78% did not have a family history that met one of the USPSTF patterns.
Conclusions: These results suggest a higher prevalence of women with an increased-risk family history than originally predicted by the USPSTF, and lack of provider recognition and referral for genetic services.
Impact: Improvements in healthcare infrastructure and clinician education will be required to realize population level benefits from BRCA genetic counseling and testing.
Conflict of interest statement
No potential conflicts of interest were disclosed.
Similar articles
-
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.JAMA. 2019 Aug 20;322(7):652-665. doi: 10.1001/jama.2019.10987. JAMA. 2019. PMID: 31429903
-
Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.Am J Prev Med. 2018 Feb;54(2):221-228. doi: 10.1016/j.amepre.2017.10.015. Epub 2017 Dec 11. Am J Prev Med. 2018. PMID: 29241717
-
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2014 Feb 18;160(4):271-81. doi: 10.7326/M13-2747. Ann Intern Med. 2014. PMID: 24366376
-
Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.Ann Intern Med. 2014 Feb 18;160(4):255-66. doi: 10.7326/M13-1684. Ann Intern Med. 2014. PMID: 24366442 Review.
-
A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?Crit Rev Oncol Hematol. 2018 Jul;127:29-41. doi: 10.1016/j.critrevonc.2018.05.008. Epub 2018 May 14. Crit Rev Oncol Hematol. 2018. PMID: 29891109 Review.
Cited by
-
Diagnostic yield of genetic screening in a diverse, community-ascertained cohort.Genome Med. 2023 Apr 18;15(1):26. doi: 10.1186/s13073-023-01174-7. Genome Med. 2023. PMID: 37069702 Free PMC article.
-
Pharmacogenetic screening in a knowledge-based economy: shouldn't more be better?Ann Transl Med. 2022 Dec;10(24):1415. doi: 10.21037/atm-2022-60. Ann Transl Med. 2022. PMID: 36660638 Free PMC article. No abstract available.
-
Development and initial testing of a multi-stakeholder intervention for Lynch syndrome cascade screening: an intervention mapping approach.BMC Health Serv Res. 2022 Nov 24;22(1):1411. doi: 10.1186/s12913-022-08732-6. BMC Health Serv Res. 2022. PMID: 36434579 Free PMC article.
-
Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care: A Cluster Randomized Clinical Trial.JAMA Netw Open. 2022 Jul 1;5(7):e2222092. doi: 10.1001/jamanetworkopen.2022.22092. JAMA Netw Open. 2022. PMID: 35849397 Free PMC article. Clinical Trial.
-
Recent Trends in Screening Breast MRI.J Breast Imaging. 2021 Dec 11;4(1):39-47. doi: 10.1093/jbi/wbab088. eCollection 2022 Jan-Feb. J Breast Imaging. 2021. PMID: 35103253 Free PMC article.
References
-
- Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst. 2006;98:1694–706. - PubMed
-
- Pal T, Permuth-Wey J, Betts JA, Krischer JP, Fiorica J, Arango H, et al. BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases. Cancer. 2005;104:2807–16. - PubMed
-
- Nelson HD, Huffman LH, Fu R, Harris EL. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services USPSTF. Ann Intern Med. 2005;143:362–79. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
